SATB1 activators constitute a diverse assemblage of chemicals intricately designed to modulate cellular signaling pathways, eliciting the activation of the Special AT-rich sequence-binding protein 1 (SATB1). These chemicals exhibit profound efficacy in influencing both the expression and functionality of SATB1 through direct or indirect mechanisms, thereby exerting a significant impact on chromatin organization and transcriptional activation within the cellular milieu. Among the indirect activators, resveratrol, a polyphenolic compound, stands out as an exemplar. It operates through the enhancement of SIRT1 activity, facilitating the deacetylation of SATB1. This deacetylation event, in turn, propels SATB1 binding to target genes, thereby playing a pivotal role in the intricate dynamics of chromatin and subsequent transcriptional activation. Concurrently, curcumin operates indirectly by inhibiting the NF-κB pathway. Its anti-inflammatory properties disrupt NF-κB signaling, alleviating the inhibitory effect on SATB1 and promoting its binding to chromatin, thereby facilitating transcriptional activation.
Expanding the repertoire of indirect activators, compounds like genistein and quercetin employ their influence by interfering with canonical signaling pathways. Genistein disrupts Wnt/β-catenin signaling, relieving the β-catenin-mediated repression of SATB1. Similarly, quercetin inhibits the JAK/STAT pathway, mitigating STAT-mediated inhibition of SATB1. These compounds exemplify the multifaceted nature of SATB1 activation, showcasing intricate crosstalk with various cellular pathways. Moreover, thymoquinone, sulforaphane, and diallyl disulfide contribute to SATB1 activation by modulating the MAPK/ERK, Nrf2, and HIF-1α pathways, respectively. These compounds further underscore the versatility inherent in SATB1 regulation, highlighting the significance of context-dependent cellular responses in the intricate orchestration of gene expression programs. In summation, SATB1 activators constitute a dynamic and versatile class of chemicals with diverse mechanisms of action. From direct modulators to those influencing interconnected signaling pathways, these compounds collectively contribute to the intricate orchestration of SATB1 activation, providing invaluable insights into potential avenues for understanding and manipulating cellular gene expression programs.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol, a polyphenolic compound, activates SATB1 by modulating the SIRT1 pathway. It enhances SIRT1 activity, leading to deacetylation of SATB1, promoting its binding to target genes and subsequent activation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin activates SATB1 indirectly by inhibiting the NF-κB pathway. Its anti-inflammatory properties disrupt the NF-κB signaling cascade, reducing SATB1 inhibition by NF-κB. This results in enhanced SATB1 binding to chromatin and transcriptional activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin gallate (EGCG) activates SATB1 by targeting the PI3K/AKT pathway. EGCG inhibits PI3K/AKT signaling, leading to decreased phosphorylation of SATB1 and enhanced DNA binding, promoting gene activation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein activates SATB1 by inhibiting the Wnt/β-catenin pathway. Its antagonistic effect on Wnt signaling disrupts the β-catenin-mediated repression of SATB1, leading to increased SATB1 expression and chromatin binding for transcriptional activation. | ||||||
Thymoquinone | 490-91-5 | sc-215986 sc-215986A | 1 g 5 g | $46.00 $130.00 | 21 | |
Thymoquinone activates SATB1 by suppressing the MAPK/ERK pathway. Inhibition of ERK phosphorylation by thymoquinone enhances SATB1 binding to chromatin, promoting transcriptional activation of SATB1 target genes. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Sulforaphane activates SATB1 indirectly by inhibiting the Nrf2 pathway. By disrupting Nrf2 signaling, sulforaphane decreases SATB1 inhibition by Nrf2, leading to enhanced SATB1 binding to chromatin and subsequent transcriptional activation. | ||||||
Allyl disulfide | 2179-57-9 | sc-252359 | 25 g | $78.00 | ||
Diallyl disulfide activates SATB1 by inhibiting the HIF-1α pathway. Its suppression of HIF-1α prevents the HIF-1α-mediated repression of SATB1, allowing for increased SATB1 binding to chromatin and subsequent transcriptional activation. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
Berberine activates SATB1 indirectly by inhibiting the AMPK pathway. Its inhibitory effect on AMPK signaling decreases SATB1 inhibition by AMPK, leading to enhanced SATB1 binding to chromatin and subsequent transcriptional activation. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Celastrol activates SATB1 by inhibiting the mTOR pathway. Its suppression of mTOR signaling reduces mTOR-mediated inhibition of SATB1, allowing for increased SATB1 binding to chromatin and subsequent transcriptional activation. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $115.00 $337.00 | 3 | |
Betulinic acid activates SATB1 by inhibiting the Hedgehog pathway. Its antagonistic effect on Hedgehog signaling disrupts the Gli-mediated repression of SATB1, leading to increased SATB1 expression and chromatin binding for transcriptional activation. | ||||||